Yakov Kogan Insider Profile

4 Followers
Yakov Kogan, CEO, Director at Statera BioPharma, holds 689.36K shares in Statera BioPharma (Ticker: STAB).
tipranks
Yakov Kogan

Yakov Kogan
Statera BioPharma (STAB)
CEO, Director

Not Ranked
Yakov Kogan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$7K
100.00%
A breakdown of Yakov Kogan's holdings

Insider Roles

Statera BioPharma
(STAB)
CEO, Director
Roles that Yakov Kogan holds in companies

Most Profitable Insider Trade

Stock:
Statera BioPharma
(STAB)
Rating:Informative Buy
Date:Aug 22, 2011 - Aug 22, 2012
Return:-21.40%
The most profitable trade made by Yakov Kogan

Yakov Kogan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Statera BioPharma
Jun 28, 2012
CEO, Director
Uninformative Buy
$6.89K
Success Rate for
STAB
0 out of 1 profitable transactions on
STAB
0%
Average Return for
STAB
Average return per transaction on
STAB
-21.40%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Aug 22, 2011
Informative Buy
$2.96K
-
$2.28
-21.40%
Jun 28, 2012
Uninformative Buy
$0.00
-
$0.00
Nov 08, 2011
Uninformative Buy
$0.00
-
$0.00
Jan 04, 2010
Uninformative Sell
$21.00K
-
$3.50
Feb 02, 2010
Uninformative Sell
$23.67K
-
$3.94
List of latest transactions for each holding click on a transaction to see Yakov Kogan's performance on stock

Yakov Kogan insider profile FAQ

What is the percentage of profitable transactions made by Yakov Kogan?
The percentage of profitable transactions made by Yakov Kogan is ―.
    What is the average return per transaction made by Yakov Kogan?
    The average return per transaction made by Yakov Kogan is ―.
      What stocks does Yakov Kogan hold?
      Yakov Kogan holds: STAB stocks.
        What was Yakov Kogan’s latest transaction?
        Yakov Kogan latest transaction was an Uninformative Buy of ―.
          What was Yakov Kogan's most profitable transaction?
          Yakov Kogan’s most profitable transaction was an Informative Buy of STAB stock on August 22, 2011. The return on the trade was -21.40%.
            What is Yakov Kogan's role in Statera BioPharma?
            Yakov Kogan's role in Statera BioPharma is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.